Evidence map›Paper›PMID 39996664›Full record

ReviewGels (Basel, Switzerland)2025

Characteristics of Polybenzoxazine Aerogels as Thermal Insulation and Flame-Retardant Materials.

Shakila Parveen Asrafali, Thirukumaran Periyasamy, Jaewoong Lee

Abstract readReview
In one paragraph

Review in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shakila Parveen AsrafaliDepartment of Fiber System Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea.ORCID 0000-0002-2638-5477
Thirukumaran PeriyasamyDepartment of Fiber System Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea.ORCID 0000-0003-1089-2615
Jaewoong LeeDepartment of Fiber System Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polybenzoxazine-based aerogels are a unique class of materials that combine the desirable properties of aerogels-such as low density, high porosity, and excellent thermal insulation-with the outstanding characteristics of polybenzoxazines-such as high thermal stability, low water absorption, and superior mechanical strength. Polybenzoxazines are a type of thermosetting polymer derived from benzoxazine monomers. Several features of polybenzoxazines can be retained within the aerogels synthesized through them. The excellent thermal resistance of polybenzoxazines, which can withstand temperatures above 200-300 °C, makes their aerogel able to withstand extreme thermal environments. The inherent structure of polybenzoxazines, rich in aromatic rings and nitrogen and oxygen atoms, imparts flame-retardant property. Their highly crosslinked structure provides excellent resistance to solvents, acids, and bases. Above all, through their molecular design flexibility, their physical, mechanical, and thermal properties can be tubed to suit specific applications. In this review, the synthesis of polybenzoxazine aerogels, including various steps such as monomer synthesis, gel formation, solvent exchange and drying, and finally curing are discussed in detail. The application of these aerogels in thermal insulation and flame-retardant materials is given importance. The challenges and future prospects of further enhancing their properties and expanding their utility are also summarized.

Indexed as

enhanced mechanical strengthlightweightPBZ aerogelssynthesis procedurethermal insulation

Identifiers

PMID39996664
PMCPMC11854720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.